Recombinant leptin exerts diverse pro-inflammatory effects on immune cell differentiation and function, including the metabolic reprogramming of immune cells and the induction of TNFα, ultimately aggravating Crohn’s disease, which can be reversed by anti-TNFα therapy. This evidence concerns the gene LEP and Crohn disease.